期刊文献+

骨形态发生蛋白-7在胃癌组织中的表达及意义 被引量:1

Expression and Clinical Significance of Bone Morphogenetic Protein-7 in Gastric Cancer
下载PDF
导出
摘要 目的分析骨形态发生蛋白-7(BMP-7)在胃癌中的表达,初步探讨BMP-7对胃癌诊断的意义。方法以27例胃癌及相应的癌旁组织为研究对象,采用实时荧光定量PCR和Western blotting方法,分别检测组织中BMP-7 mRNA及其蛋白的表达情况。结果27例配对的胃癌及其癌旁组织中,63.0%(17/27)的癌组织BMP-7 mRNA的表达高于癌旁组织,差异有统计学意义(t=2.94,P〈0.01,配对t检验);Western blotting结果显示,77.8%(7/9)的癌组织BMP-7蛋白水平的表达高于癌旁组织,差异有统计学意义(t=2.57,P%0.05,配对t检验)。结论胃癌组织中BMP-7的表达高于癌旁组织,可能与胃癌的发生、发展相关,对临床胃癌的辅助诊断可能具有潜在价值。 Objective To preliminarily investigate the expression of BMP-7 in gastric cancer and its significance for gastric cancer diagnosis. Methods The expression level of BMP-7 mRNA in 27 pair-matched gastric neoplastic and adjacent non ne oplastic tissues was determined by quantitative reverse transcriptase polymerase chain reaction, and western blotting was performed to analyze BMP 7 protein level in randomly selected 9 pair-matched tissues. Results The relative expression level of BMP-7 mRNA in 63.0% (17/27) gastric cancer tissues was significantly higher than that in adjacent non-neoplastic tis- sues (t=2.57,P〈0.05,paired t-test). The level of BMP-7 protein in 77.8%(7/9) gastric cancer tissues was higher than that in adjacent non-neoplastic tissues (t= 2.57, P〈0.05, paired t-test). Conelasion Compared to the non neoplastic tissues,expression of BMP 7 was increased in gastric cancer,indicating BMP-7 might be associated with the occurrence and development of gastric cancer,and may have potential value for the diagnosis of gastric cancer.
出处 《现代检验医学杂志》 CAS 2015年第6期18-19,24,共3页 Journal of Modern Laboratory Medicine
基金 南京市医学科技发展重点项目(ZKX08030)、专项课题(YKK13066).
关键词 胃癌 骨形态发生蛋白-7 gastric cancer bone morphogenetic protein-7
  • 相关文献

参考文献10

  • 1Wozney JM, Rosen V, Celeste AJ, et al. Novel regula tors of bone formation:molecular clones and activities [J]. Sciense, 1988,242(4885) : 1528-1534.
  • 2Boon MR,van der Horst G,van der Pluijm G,et at. Bone morphogenetic protein 7: a broad-spectrum growth factor with multiple target therapeutic poten- ey[J]. Cytokine Growth Factor Rev,2011,22(4) :221- 229.
  • 3Alarmo EL, Parssinen J, Ketolainen JM, et al. BMP7 in uences proliferation, migration, and invasion of breast cancer cells[J]. Cancer I.ett,2009,275(1) : 35- 43.
  • 4Beck SE, 3 ung BH, Fiorino A, et al. Bone morphoge netic protein signaling and growth suppression in co Ion cancer[J]. Am J Physiol Gastrointest Liver Physi ol,2006,291(1) :G135- 145.
  • 5Sakai H, Furihata M, Matsuda C, et al. Augmented autocrine bone morphogenic protein (BMP) 7 signa- ling increases the metastatic potential of mouse breast cancer ceils[J].Clin Exp Metastasis, 2012, 29 ( 4 ) : 327-338.
  • 6Motoyama K,Tanaka F, Kosaka Y, et al. Clinical sig nificance of BMP7 in human colorectal cancer[J]. Ann Surg Oncol,2008,15(5) :1530-1537.
  • 7Kwak C,Park YH,Kim IY,et al. Expression of bone morphogenetic proteins, the subfamily of the transfor ming growth factor-beta superfamily,in renal cell car- cinoma[J].J Urol,2007,178(3 Dt 1):1062-1067.
  • 8邢瑞青,吴永昌,邹海,张涛,王菁,金亚莉,赵茜,秦爽,彭道荣.不同血清肿瘤标志物对胃癌诊断价值的临床研究[J].现代检验医学杂志,2014,29(6):102-106. 被引量:14
  • 9王妍,姚伟,黄钦贤,林章礼,郭少君.胃癌患者的血清乳酸脱氢酶水平及其基因在癌组织的表达与患者预后的相关性研究[J].现代检验医学杂志,2014,29(5):54-57. 被引量:7
  • 10Aoki M,Ishigami S, Uenosono Y, et al. l:.xpresslon of BMP-7 in human gastric cancer and its clinical significance[J ]. Br J Cancer, 2011,104 (4) : 714- 718.

二级参考文献27

  • 1王轶.胃癌病程分期与血清CA724、CA242及CEA水平关系探讨[J].放射免疫学杂志,2006,19(3):225-226. 被引量:45
  • 2龚立鹏,张颖,张本华,刘文健,肖宝荣.乳酸脱氢酶与食管癌转移的临床研究[J].泰山医学院学报,2006,27(5):434-436. 被引量:5
  • 3Hirschhaeuser F, Sattler UG, Mueller-Klieser W. La- ctate:a metabolic key player in cancer[J]. Cancer Res,2011,71(22) :6921-6925.
  • 4Kim JW,Gao P,Liu YC,et al. Hypoxia-inducible fac tor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic swit ches hexokinase 2 and pyruvate dehydrogenase kinase 1[J]. Mol Cell Biol,2007,27(21) :7381-7393.
  • 5Hsu PP, Sabatini DM. Cancer cell metabolism: War burg and beyond[J]. Cell, 2008,134 (5) : 703-707.
  • 6Koukourakis MI, Giatromanolaki A, Sivridis E, et al. Prognostic and predictive role of lactate dehydrogen ase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584(vatalanib) antiangiogenic thetapy[J]. Clin Cancer Res, 2011,17(14):4892- 4900.
  • 7Armstrong AJ, George DJ, Halabi S. Serum lactate dehydrogenas predicts for overall survival benefit in patients with metastatic renal cell carcinoma treatedwith inhibition of mammalian target of rapamycin EJJ- J Clin Oncol,2012,30(27) :3402-3407.
  • 8Eigentler TK,Figl A,Krex D,et al. Number of me- tastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma[J]. Cancer, 2011,117 (8) :1697-1703.
  • 9Kolev Y, Uetake H, Takagi Y, et al. Lactate dehy- drogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-la) pathway, angiogenic factors productionand poor prognosis[J]. Ann Surg Oncol, 2008, 15 (8) : 2336-2344.
  • 10Lu H, Li X, Luo Z, et al. Cetuximab reverses the warburg effect by inhibiting HIF-l-regulated LDH- A[J]. Mol Cancer Ther,2013,12(10):2187-2199.

共引文献19

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部